In vitro study involving RKO CRC cell line with BRAFV600E and MSI-H phenotype treated with immune checkpoint inhibitors and anti-EGFR upregulated autophagy and PD-L1 levels via MEK/ERK signaling pathway. The gene discussed is MAP2K7; the disease is colorectal carcinoma.